EMEA-002942-PIP02-20-M02 - paediatric investigation plan

survodutide

Key facts

• Active substance:
  survodutide
• Therapeutic area:
  Metabolism and nutrition disorders
• Decision number:
  P/0259/2024
• PIP number:
  EMEA-002942-PIP02-20-M02
• Pharmaceutical form(s):
  Solution for injection in pre-filled syringe
• Condition(s) / indication(s):
  Treatment of obesity
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  16/08/2024
• Compliance check done:
  Ne

Decision

P/0259/2024: EMA decision of 16 August 2024 on the acceptance of a modification of an agreed paediatric investigation plan for survodutide (EMEA- 002942-PIP02-20-M02)

Adopted Reference Number: EMA/364874/2024